News

News

Dr Tim Thomas and Dr Anne Voss standing in lab with notebook

The discovery of a ‘switch’ that modifies a gene known to be essential for normal heart development could explain variations in the severity of birth defects in children with DiGeorge syndrome.

24 August 2012
Dr Wai-Hong Tham in the lab

Infectious disease research at the Walter and Eliza Hall Institute has received a $2.1 million boost thanks to the Australian Research Council (ARC) Future Fellowships program.

3 August 2012
Dr Jeff Babon and Professor Nick Nicola in the lab

Walter and Eliza Hall Institute scientists have revealed new details about how cell signalling is controlled in the immune system, identifying in the process potential new therapeutic targets for treating severe blood disorders.

17 February 2012
Immunology researchers discussing research

In a major shake-up of scientists’ understanding of what determines the fate of cells, researchers at the Walter and Eliza Hall Institute have shown that cells have some control over their own destiny.

6 January 2012
Professor Stephen Nutt in the lab

Walter and Eliza Hall Institute researcher Dr Stephen Nutt has been awarded a $200,000 Multiple Myeloma Research Foundation (MMRF) grant to study key immune cell genes and their role in cancer.

6 October 2011
Dr Emma Josefsson in the lab

Scientists at the Walter and Eliza Hall Institute have identified a way that chemotherapy causes platelet numbers to drop, answering in the process a decade-old question about the formation of platelets, tiny cells that allow blood to clot.

26 September 2011
Dr Bob Anderson and Dr Jason Tye-Din in the lab working on a coeliac disease vaccine

The world’s first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.

8 May 2011

Pages